N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144052 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144053 |
| CAS No | NA |
| Mol.F. | C8H11N5O4 |
| Mol.Wt. | 241.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144054 |
| CAS No | NA |
| Mol.F. | C9H8FN3O3 |
| Mol.Wt. | 225.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144055 |
| CAS No | NA |
| Mol.F. | C17H18N4O7 |
| Mol.Wt. | 390.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144056 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144057 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144058 |
| CAS No | NA |
| Mol.F. | C23H22FN5O6 |
| Mol.Wt. | 483.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144059 |
| CAS No | NA |
| Mol.F. | C24H22FN9O8 |
| Mol.Wt. | 583.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144060 |
| CAS No | NA |
| Mol.F. | C6H9N3O5 |
| Mol.Wt. | 203.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144061 |
| CAS No | NA |
| Mol.F. | C7H13N3O5 |
| Mol.Wt. | 219.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144062 |
| CAS No | NA |
| Mol.F. | C3H5N3O5 |
| Mol.Wt. | 163.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144063 |
| CAS No | NA |
| Mol.F. | C16H19N5O4 |
| Mol.Wt. | 345.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144064 |
| CAS No | NA |
| Mol.F. | C19H16F3N3O4S |
| Mol.Wt. | 439.41 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0144065 |
| CAS No | NA |
| Mol.F. | C11H13ClN2O |
| Mol.Wt. | 224.69 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144066 |
| CAS No | NA |
| Mol.F. | C31H40N6O3S |
| Mol.Wt. | 576.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144067 |
| CAS No | NA |
| Mol.F. | C16H21N3O |
| Mol.Wt. | 271.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |